Novel use of Polymerase I inhibitor

A technology of inhibitor and immunosuppressant, applied in the field of biomedicine, can solve the problem that the effect of CX-5461 has not been reported, and achieve the effect of inhibiting the proliferation of T cells and having great application prospects.

Active Publication Date: 2018-11-30
SUN YAT SEN UNIV
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, there is no report on t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel use of Polymerase I inhibitor
  • Novel use of Polymerase I inhibitor
  • Novel use of Polymerase I inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0047] Example 1 Cx5461 affects T cell activation by inhibiting the proliferation of T cells

[0048] Dissolve Cx5461 in dimethyl sulfoxide (DMSO) to make a Cx5461 solution and perform the following experiments:

[0049] 1. Inoculate Jurkat T cells in a six-well plate of RPMI1640 medium containing 10% fetal bovine serum, and divide them into four groups.

[0050] (1) Stimulation group (P / I): Add PMA / Ionmycin solution to each well;

[0051] (2) Positive control group (P / I+FK506): Add FK506 solution to each well until the concentration of FK506 is 1×10 -6 M;

[0052] (3) Experimental group (P / I+Cx5461): Add Cx5461 solution to each well until the concentration of Cx5461 is 1×10 -6 M;

[0053] (4) Control group (Con): add equal volume of DMSO to each well;

[0054] The above four groups were cultured at 37°C for 6 hours and then subjected to immunofluorescence experiments. Suspend Jurkat T cells in 50 mL culture medium, install filter paper and fixed glass slide on the cell spinner, then add...

Example Embodiment

[0077] Example 2 Cx5461 delayed the rejection of skin allograft at the level of animal experiments

[0078] Take 2 g of Cx5461 and dissolve it in 1 mL of DMSO liquid. After the dissolution is complete, add physiological saline to make up the volume so that the final concentration of Cx5461 is 0.5 g / L, 1.0 g / L, 2.0 g / L to obtain the Cx5451 solution. experiment:

[0079] 1. Mouse skin transplantation experiment

[0080] (1) Establishment of mouse skin transplantation model

[0081] The laboratory purchased C57BL / 6 and C57BL / 6 at the age of 6-8 weeks in the Guangdong Medical Experimental Animal Center and kept them in the breeding room of the Shenzhen Graduate School of Tsinghua University. Two days before the operation, the recipient's C57BL / 6 mice were depilated; BALB / c mice and C57BL / 6 mice were anaesthetized with 10% sodium pentobarbital, and 75% ethanol was used to treat the donor and The back skin of the recipient mice was disinfected. The back skin of the donor mouse was remove...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of biological medicine and specifically discloses a novel use of a Polymerase I inhibitor. The novel use of the Polymerase I inhibitor is studied in the cellular level and the animal experimental level. The Polymerase I inhibitor can inhibit the activity of IL-2, NFATc2, NFkB and IFN-gamma thereby inhibiting the proliferation of T cells, further regulating and controlling the T cell activation and the immune response of the human body and inhibiting the immune rejection of the organ allograft. The Polymerase I inhibitor can be used for preparation of agents for inhibiting the activity of IL-2, NFATc2, NFkB and IFN-gamma, T cell proliferation, T cell activation or immune rejection of the organ allograft and has a large application prospect.

Description

technical field [0001] The invention belongs to the technical field of biomedicine. More specifically, it relates to the use of Polymerase I inhibitors in the preparation of immunosuppressants. Background technique [0002] The existence of the immune system is to prevent the invasion of pathogenic bacteria, but some cells, tissue proteins or other components in some individuals will have an abnormal immune reaction with the immune system, and the individual will produce T cells that attack their own cells or any proteins outside the cells or Lesions caused by autoantibodies are autoimmune diseases. The etiology of autoimmune diseases is extremely complex, so the current clinical treatment can only start from the symptoms of the appearance, such as giving patients immunosuppressants to relieve their pain. In a broad sense, drugs that can reduce immunity are called immunosuppressants, which can reduce immunity after taking or injection. Therefore, immunosuppressants are ma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/551A61P37/06
CPCA61K31/551A61P37/06
Inventor 陈红波蔡湘仪杨敏吴彦萍邓文斌
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap